Novo Nordisk introduces updated Rybelsus tablet formulation in Canada: June 9, 2026 announcement of the new 1.5, 4, and 9 mg strengths replacing 3, 7, and 14 mg
The FDAs Pharmacy Compounding Advisory Committee will meet on July 23 and 24 to consider if seven peptides should be added to the agencys 503A Bulks List, a step that would permit state-licensed compounding pharmacies to prepare the substances for patients with prescriptions
The solution should be clear, colorless to slightly yellow, with no visible particles
Sobo provides guidance that helps patients separate promising research from overhyped claims, especially when a peptide is being discussed online before the evidence is mature enough to support broad claims
With continuous injection mode and a dual-rotor system, it allows for uninterrupted purification, greater throughput, and scalability